Continuous glucose monitoring can be successfully initiated during hospitalization with training for hospital staff, robust ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc. – DXCM
Pomerantz LLP is investigating claims on behalf of investors of DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: ...
Most continuous glucose monitoring metrics were not associated with HbA1c for adults with normal glycemic levels, according ...
With significant upside potential, DexCom, Inc. (NASDAQ:DXCM) secures a spot on our list of the 13 Best Quality Stocks to Buy ...
We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. DexCom, Inc. is one of them. DexCom ...
Mass General Brigham researchers found that continuous glucose monitoring metrics were reflective of a common measure of glucose (hemoglobin A1c) in patients with diabetes, but fell short for people w ...
The FDA has granted de novo classification to the Biolinq Shine wearable biosensor, which would be the first needle-free CGM ...
Now, it’s worth noting Stock Advisor's total average return is 1,079% — a market-crushing outperformance compared to 191% for the S&P 500. Don’t miss out on the latest top 10 list, available when you ...
Global equities are likely to continue edging higher even as valuation concerns continue to arouse fear among investors.
Shares of DexCom (NASDAQ:DXCM) fell for the third straight session on Friday to reach the lowest level since April, even as ...
Next presentation this afternoon is from DexCom, a leader in developing and commercializing continuous glucose monitoring systems for people with diabetes and I'm sure in the future beyond diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback